Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

about

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China.Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.

P2860

Q37719675-1E620200-2C00-4D8C-95F8-9C15C3E9BD2D Q40098532-4FC5A741-3C40-475D-8EE5-3B3CAF83C4CC

P2860

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

Item

http://www.wikidata.org/entity/Q35954220

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of Therapeutic Resp ...... al Alanine Transaminase Levels

@ast

Comparison of Therapeutic Resp ...... al Alanine Transaminase Levels

@en

type

Item

label

Comparison of Therapeutic Resp ...... al Alanine Transaminase Levels

@ast

Comparison of Therapeutic Resp ...... al Alanine Transaminase Levels

@en

prefLabel

Comparison of Therapeutic Resp ...... al Alanine Transaminase Levels

@ast

Comparison of Therapeutic Resp ...... al Alanine Transaminase Levels

@en

P1476

Comparison of Therapeutic Resp ...... al Alanine Transaminase Levels

@en

P2093

Chao-Hung Hung

http://www.w3.org/2001/XMLSchema#string

Cheng-Kung Wu

http://www.w3.org/2001/XMLSchema#string

Chien-Hung Chen

http://www.w3.org/2001/XMLSchema#string

Chuan-Mo Lee

http://www.w3.org/2001/XMLSchema#string

Jing-Houng Wang

http://www.w3.org/2001/XMLSchema#string

Kuo-Chin Chang

http://www.w3.org/2001/XMLSchema#string

Ming-Tsung Lin

http://www.w3.org/2001/XMLSchema#string

Po-Lin Tseng

http://www.w3.org/2001/XMLSchema#string

Sheng-Nan Lu

http://www.w3.org/2001/XMLSchema#string

Tsung-Hui Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Hepatitis C virus infection

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Diagnosis, management, and treatment of hepatitis C: an update

Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.

Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?

Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases

Treatment of patients with hepatitis C and normal serum aminotransferase levels.

P304

e0142378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0142378

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297898973

http://www.w3.org/2001/XMLSchema#string

P698

26968010

http://www.w3.org/2001/XMLSchema#string

P932

4788146

http://www.w3.org/2001/XMLSchema#string

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

about

P2860

P2860

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932